Loading...

d2322's Recent CancerCompass Activity

  • d2322 has created a new message board discussion

    CONCLUSIONS:
    HIFU provides good biochemical control through 10 years of follow-up with a mild morbidity profile. Negative biopsy rates are high across all risk groups. These long term outcomes represent HIFU emerging from investigational status to become a standard primary treatment option. 

    I hope someone can see this at the AUA on May 16???

    view discussion
    • d2322 has created a new message board discussion

      ·    I Found this Abstract on the AUA website      INTRODUCTION AND OBJECTIVES:The utilization of HIFU as a primary therapy for prostate cancer continues to increase. The objective of this study is to report 10 year biochemical and biopsy outcomes of patients who have undergone HIFU and were followed with the @-Registry. This is the largest HIFU series ever reported.  M...

      view discussion
      • d2322 has created a new message board discussion

        ·    I Found this Abstract on the AUA website      INTRODUCTION AND OBJECTIVES:The utilization of HIFU as a primary therapy for prostate cancer continues to increase. The objective of this study is to report 10 year biochemical and biopsy outcomes of patients who have undergone HIFU and were followed with the @-Registry. This is the largest HIFU series ever reported.  M...

        view discussion
        Loading...
        Load more activity
        Loading more activity

        About d2322

        Researcher
        Prostate Cancer, Colon Cancer

        We care about your feedback. Let us know how we can improve your CancerCompass experience.